Abraxane cancer trial shows positive results in Australia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: Specialised Therapeutics Australia (STA) is going to publish abstracts related to its phase III metastatic me...Read more
Astellas, Ambit terminate cancer drug deal
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Mar, 2013
Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint d...Read more
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Dec, 2013
Singapore: Roche has launched FLOW system, a user defined system for workflow chain from primary sample handling to qPCR...Read more
TB prevention faces gap of $1.6bn: WHO estimates
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to...Read more
Edison Pharma, DSP enter $4 bn metablosim drug deal
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2014
Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan'...Read more
Gilead files NDA for Hep C drug in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Jun, 2014
Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Dev...Read more
GSK gets EU nod for metastatic melanoma inhibitor
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 24 Apr, 2013
Singapore: GlaxoSmithKline has recieved European Commission (EC) marketing authorisation for Mekinist (trametinib) as a ...Read more
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Brisbane drug discovery and development company Alchemia announces that Mr Charles Walker has been appointed...Read more
Merck Millipore enhances bioavailability portfolio
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Oct, 2012
Singapore: Merck Millipore is boosting its portfolio for drug bioavailability, including products for all types of dosag...Read more
Singapore scientists, clinicians collaborate on 8 projects
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Singapore has announced 8 biomedical sciences research programmes to advance understanding and treatment of d...Read more
Boehringer Ingelheim enriches drug pipeline
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2012
Singapore: Boehringer Ingelheim, one of the world's leading pharmaceutical companies, will acquire the global rights of ...Read more
China will overtake Japan in R&D spending: Report
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2013
Singapore: China's biomedical sector is rapidly transforming itself from a manufacturing base to an innovation hub, inve...Read more
Astellas gets FDA nod for kidney transplant drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2013
Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsule...Read more
Global collaborations is the way forward for drug discovery
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 19 Dec, 2012
Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry ser...Read more
NIH gives $2.2 mn to VaxInnate for dengue vaccine
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Apr, 2013
Singapore: National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has provi...Read more
Janssen to develop therapy for immunological diseases
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Janssen Biotech has entered into a license agreement with Astellas Pharma for the worldwide development and c...Read more
European Commission nod for Novartis' Exjade
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 26 Dec, 2012
Singapore: European Commission has approved Exjade (deferasirox) for the treatment of chronic iron overload requiring ch...Read more
CSL hemophilia therapy gets orphan drug status
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 11 Jun, 2012
Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP...Read more